ProMeris
Withdrawn
metaflumizone
MedicineVeterinaryWithdrawn
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
The marketing authorisation for ProMeris has been withdrawn at the request of the marketing authorisation holder.
Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).